The multidisciplinarity of stage III non-small cell lung cancer

European Journal of Cancer

Volumn 45, Issue SUPPL. 1, 2009, Pages 92-105

  Vansteenkiste, Johan ^a   Dooms, Christophe ^a   De Leyn, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANTERIOR MEDIASTINOTOMY; ARTICLE; ASPIRATION BIOPSY; BRONCHOSCOPY; CANCER STAGING; CANCER SURGERY; CERVICAL MEDIASTINOSCOPY; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DECISION MAKING; DIAGNOSTIC ACCURACY; ENDOBRONCHIAL ULTRASONOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; THORACOSCOPY; TRANSBRONCHIAL ASPIRATION; VIDEO ASSISTED THORACIC SURGERY;

BIOPSY, NEEDLE; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; DECISION MAKING; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDIASTINOSCOPY; NEOPLASM STAGING; PATIENT CARE TEAM; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349119461     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(09)70021-8     Document Type: Article

References (85)

1. The International Adjuvant Lung Cancer Trial Collaborative Group, Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., and Vansteenkiste J. Cisplatin-based adjuvant chemother-apy in patients with completely resected non-small cell lung cancer. N Engl J Med 350 (2004) 351-360
2. Rosell R., Gomez Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
3. Vansteenkiste J., De Leyn P., Deneffe G., Menten J., Lerut T., Demedts M., and Leuven Lung Cancer Group. Present status of induction treatment for N2 non-small cell lung cancer : A review. Eur J Cardiothorac Surg 13 (1998) 1-12
4. Eberhardt W., Stuschke M., and Stamatis G. Preoperative chemoradiation approaches to locally advanced non-small cell lung cancer: one man's pride, another man's burden?. Ann Oncol 15 (2004) 365-367
5. Lorent N., De Leyn P., Lievens Y., et al., Leuven Lung Cancer Group. Long-term survival of surgically staged IIIA-N2 non-small cell lung cancer treated with surgical combined modality approach: analysis of a 7-year experience. Ann Oncol 15 (2004) 1645-1653
6. Izbicki J.R., Thetter O., Karg O., et al. Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma. A prospective study. J Thorac Cardiovasc Surg 104 (1992) 413-420
7. Bittner R.C., and Felix R. Magnetic resonance (MR) imaging of the chest: state-of-the-art. Eur Respir J 11 (1998) 1392-1404
8. Hierholzer J., Luo L., Bittner R.C., et al. MRI and CT in the differential diagnosis of pleural disease. Chest 118 (2000) 604-609
9. Silvestri G.A., Gould M.K., Margolis M.L., et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132 Suppl 3 (2007) 178S-201S
10. Antoch G., Stattaus J., Nemat A.T., et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229 (2003) 526-533
11. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16 (1998) 2142-2149
12. Fischer B.M., Mortensen J., and Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2 (2001) 659-666
13. Gould M.K., Kuschner W.G., Rydzak C.E., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer: a meta-analysis. Ann Intern Med 139 (2003) 879-892
14. Stroobants S., Dhoore I., Dooms C., et al. Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small cell lung cancer. Clinical Lung Cancer 4 (2003) 242-247
15. Pieterman R.M., Van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small cell lung cancer with positron emission tomography. N Engl J Med 343 (2000) 254-261
16. Vesselle H., Pugsley J.M., Vallieres E., and Wood D.E. The impact of fluorodeoxyglucose F18 positron emission tomography on the surgical staging of non-small cell lung cancer. J Thorac Cardiovasc Surg 124 (2002) 511-519
17. Mac Manus M.P., Hicks R.J., Matthews J.P., et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 287-293
18. Eschmann S.M., Friedel G., Paulsen F., et al. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eur J Nucl Med Mol Imaging 29 (2002) 804-808
19. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al., Leuven Lung Cancer Group. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer : A prospective analysis of 50 cases. Chest 112 (1997) 1480-1486
20. Weng E., Tran L., Rege S., et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol 23 (2000) 47-52
21. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
22. Cerfolio R.J., Ojha B., Bryant A.S., Raghuveer V., Mountz J.M., and Bartolucci A.A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 78 (2004) 1017-1023
23. Halpern B.S., Schiepers C., Weber W.A., et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 128 (2005) 2289-2297
24. De Wever W., Ceyssens S., Mortelmans L., et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 17 (2007) 23-32
25. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., Dupont P.J., Bogaert J., Verbeken E.K., and Leuven Lung Cancer Group. Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIA-N2 non-small cell lung cancer : A prospective pilot study. Ann Oncol 9 (1998) 1193-1198
26. 18Fluoro-2-deoxyglucose positron emission tomography (PET) in the assessment of induction chemotherapy (IC) in stage IIIA-N2 NSCLC: A multi-center prospective study. Proc ASCO 20 (2001) 313A
27. Akhurst T., Downey R.J., Ginsberg M.S., et al. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73 (2002) 259-266
28. Ryu J.S., Choi N.C., Fischman A.J., Lynch T.J., and Mathisen D.J. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 35 (2002) 179-187
29. Cerfolio R.J., Ojha B., Mukherjee S., Pask A.H., Bass C.S., and Katholi C.R. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J Thorac Cardiovasc Surg 125 (2003) 938-944
30. Hellwig D., Graeter T.P., Ukena D., Georg T., Kirsch C.M., and Schafers H.J. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma. J Thorac Cardiovasc Surg 128 (2004) 892-899
31. Port J.L., Kent M.S., Korst R.J., Keresztes R., Levin M.A., and Altorki N.K. Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. Ann Thorac Surg 77 (2004) 254-259
32. 18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small cell lung cancer. J Clin Oncol 23 (2005) 8362-8370
33. Cerfolio R.J., Bryant A.S., and Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg 131 (2006) 1229-1235
34. Pottgen C., Levegrun S., Theegarten D., et al. Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 12 (2006) 97-106
35. De Leyn P., Stroobants S., De Wever W., et al. Prospective comparative study of integrated positron emission tomography-computed tomography compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy proven stage IIIA-N2 non-small cell lung cancer: A Leuven Lung Cancer Group study. J Clin Oncol 24 (2006) 3333-3339
36. Eschmann S.M., Friedel G., Paulsen F., et al. Repeat (18)F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Lung Cancer 55 (2007) 165-171
37. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
38. Piet A.H., Lagerwaard F.J., Kunst P.W., Van Sornsen de Koste J.R., Slotman B.J., and Senan S. Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging?. Chest 131 (2007) 1783-1787
39. Detterbeck F.C., Jantz M., Wallace M., Vansteenkiste J., Silvestri G.A., and American College of Chest Physicians (ACCP). Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 Suppl 3 (2007) 202S-220S
40. Micames C.G., McCrory D.C., Pavey D.A., Jowell P.S., and Gress F.G. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and meta-analysis. Chest 131 (2007) 539-548
41. Gu P., Zhao Y.Z., Jiang L.Y., Zhang W., Xin Y., and Han B.H. Endo-bronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis. Eur J Cancer (2009)
42. Annema J.T., Veselic M., Versteegh M.I., Willems L.N., and Rabe K.F. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer 42 (2003) 311-318
43. Varadarajulu S., and Eloubeidi M. Can endoscopic ultrasonography-guided fine-needle aspiration predict response to chemoradiation in non-small cell lung cancer? A pilot study. Respiration 73 (2006) 213-220
44. Herth F.J., Annema J.T., Eberhardt R., et al. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol 26 (2008) 3346-3350
45. De Leyn P., and Lerut T. Conventional mediastinoscopy. Multimedia Manual of Cardiothoracic Surgery (2004) 10.1510/mmcts.2004.000158
46. Smulders S.A., Smeenk F.W., Janssen-Heijnen M.L., Wielders P.L., De Munck D.R., and Postmus P.E. Surgical mediastinal staging in daily practice. Lung Cancer 47 (2005) 243-251
47. De Leyn P., Lardinois D., Van Schil P., et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32 (2007) 1-8
48. De Leyn P., and Lerut T. Videomediastinoscopy. Multimedia Manual of Cardiothoracic Surgery (2004) 10.1510/mmcts.2004.000166
49. Lardinois D., Schallberger A., Betticher D., and Ris H.B. Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer. Ann Thorac Surg 75 (2003) 1102-1106
50. Venissac N., Alifano M., and Mouroux J. Video-assisted mediastinoscopy: experience from 240 consecutive cases. Ann Thorac Surg 76 (2003) 208-212
51. Martin-Ucar A.E., Chetty G.K., Vaughan R., and Waller D.A. A prospective audit evaluating the role of video-assisted cervical mediastinoscopy (VAM) as a training tool. Eur J Cardiothorac Surg 26 (2004) 393-395
52. Lopez L., Varela A., Freixinet J., et al. Extended cervical mediastinoscopy: prospective study of fifty cases. Ann Thorac Surg 57 (1994) 555-558
53. Freixinet Gilart J., Garcia P.G., De Castro F.R., Suarez P.R., Ro-driguez N.S., and De Ugarte A.V. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma. Ann Thorac Surg 70 (2000) 1641-1643
54. Urschel J.D., Vretenar D.F., Dickout W.J., and Nakai S.S. Cerebrovascular accident complicating extended cervical mediastinoscopy. Ann Thorac Surg 57 (1994) 740-741
55. Mateu-Navarro M., Rami-Porta R., Bastus-Piulats R., Cirera-Nogueras L., and Gonzalez-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 391-395
56. Marra A., Hillejan L., Fechner S., and Stamatis G. Remediastinoscopy in restaging of lung cancer after induction therapy. J Thorac Cardiovasc Surg 135 (2008) 843-849
57. De Waele M., Serra-Mitjans M., Hendriks J., et al. Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small cell lung cancer in a combined series of 104 patients. Eur J Cardiothorac Surg 33 (2008) 824-828
58. Pitz C.C., Maas K.W., Van Swieten H.A., Brutel de la Riviere A., Hofman P., and Schramel F.M. Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer. Ann Thorac Surg 74 (2002) 164-169
59. Van Schil P., Van Der Schoot J., Poniewierski J., et al. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer 37 (2002) 281
60. Stamatis G., Fechner S., Hillejan L., Hinterthaner M., and Krbek T. Repeat mediastinoscopy as a restaging procedure. Pneumologie 59 (2005) 862-866
61. De Leyn P., Vansteenkiste J., Cuypers P., et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 12 (1997) 706-712
62. Annema J.T., Versteegh M.I., Veselic M., et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA 294 (2005) 931-936
63. Andre F., Grunenwald D., Pignon J.P., et al. Survival of patients with resected N2 non-small cell lung cancer: Evidence for a subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
64. Bach P.B., Cramer L.D., Schrag D., Downey R.J., Gelfand S.E., and Begg C.B. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 345 (2001) 181-188
65. Little A.G., Rusch V.W., Bonner J.A., et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80 (2005) 2051-2056
66. Cheung M.C., Hamilton K., Sherman R., et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: An examination of 13,469 surgical patients. Ann Surg Oncol 16 (2009) 1001-1009
67. Meguid R.A., Brooke B.S., Chang D.C., Sherwood J.T., Brock M.V., and Yang S.C. Are surgical outcomes for lung cancer resections improved at teaching hospitals?. Ann Thorac Surg 85 (2008) 1015-1025
68. Sioris T., Sihvo E., Sankila R., and Salo J. Effect of surgical volume and hospital type on outcome in non-small cell lung cancer surgery: A Finnish population-based study. Lung Cancer 59 (2008) 119-125
69. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
70. Birkmeyer J.D., Sun Y., Wong S.L., and Stukel T.A. Hospital volume and late survival after cancer surgery. Ann Surg 245 (2007) 777-783
71. Lee J.S., Scott C.B., Komaki R., Ettinger D.S., and Sause W.T. Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 362-370
72. Davison A.G., Eraut C.D., Haque A.S., et al. Telemedicine for multidisciplinary lung cancer meetings. J Telemed Telecare 10 (2004) 140-143
73. Martin-Ucar A.E., Waller D.A., Atkins J.L., Swinson D., O'Byrne K.J., and Peake M.D. The beneficial effects of specialist thoracic surgery on the resection rate for non-small cell lung cancer. Lung Cancer 46 (2004) 227-232
74. Forrest L.M., McMillan D.C., McArdle C.S., and Dunlop D.J. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 93 (2005) 977-978
75. Seek A., and Hogle W.P. Modeling a better way: navigating the healthcare system for patients with lung cancer. Clin J Oncol Nurs 11 (2007) 81-85
76. Egger M., and Smith G.D. Bias in location and selection of studies. Br Med J 316 (1998) 61-66
77. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
78. Dillman R.O., and Chico S.D. Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks. J Onco Pract 1 (2008) 84-92
79. Pisters K.M., Evans W.K., Azzoli C.G., et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small cell lung cancer guideline. J Clin Oncol 25 (2007) 5506-5518
80. Vansteenkiste J., Betticher D., Eberhardt W., and De Leyn P. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer [editorial]. J Thorac Oncol 2 (2007) 684-685
81. Van Meerbeeck J.P., Kramer G.W., Van Schil P.E., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
82. Betticher D.C., Hsu Schmitz S.F., Totsch M., et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer 94 (2006) 1099-1106
83. Eberhardt W., Wilke H., Stamatis G., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol 16 (1998) 622-634
84. Albain K.S., Swann R.S., Rusch V.W., et al., North American Lung Cancer Intergroup. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer: Outcomes update of North-American Intergroup 0139 (RTOG 9309). J Clin Oncol 23 Suppl 1 (2005) 624S
85. Dooms C., Verbeken E., Stroobants S., Nackaerts K., De Leyn P., and Vansteenkiste J. Prognostic stratification of stage IIIA-N2 non-small cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. J Clin Oncol 26 (2008) 1128-1134